JANSSEN PHARMACEUTICA NV

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

# of Matters
2015201620172018
0502575

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 85511
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7883
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 11120
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 716
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5385
 
  
 
C07K PEPTIDES 4789
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 44162
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 26141
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 2149
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 17108

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,295 BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOFJul 21, 17Mar 15, 18[A61K]
2018/0050,005 Concentrated Solution of 17-Hydroxydocosahexaenoic AcidNov 17, 16Feb 22, 18[C11B, A61K, C12P, C11C, B01D]
2018/0050,107 NEUROSTEROID COMPOSITIONS AND METHODS OF USE THEREOFAug 15, 17Feb 22, 18[A61K]
2018/0022,827 ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOFSep 01, 17Jan 25, 18[G01N, C07K]
2018/0009,814 SYNTHESIS OF A BRUTON?S TYROSINE KINASE INHIBITORJan 14, 16Jan 11, 18[C07D]
2018/0000,810 DISPERSIBLE COMPOSITIONSJan 26, 16Jan 04, 18[A61K]
2017/0368,025 COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREAMENT OF HYPERURICEMIASep 07, 17Dec 28, 17[A61K]
2017/0298,147 ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOFApr 20, 17Oct 19, 17[G01N, C07K]
2017/0299,618 ANTIBODIES TO RISPERIDONE AND USE THEREOFMay 08, 17Oct 19, 17[G01N, C07K]
2017/0240,653 ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOFMay 09, 17Aug 24, 17[C12N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920040 GPR40 agonists for the treatment of type II diabetesAug 04, 16Mar 20, 18[C07D]
9908873 GPR40 agonists for the treatment of type II diabetesAug 04, 16Mar 06, 18[C07D]
9884878 FLAP modulatorsJun 02, 15Feb 06, 18[A61K, C07F, C07D]
9861618 Thiazoles as modulators of RORγtOct 30, 15Jan 09, 18[A61K, C07D]
9856245 GPR40 agonists for the treatment of type II diabetesAug 04, 16Jan 02, 18[C07D]
9850236 Trifluoromethyl alcohols as modulators of RORγtOct 30, 15Dec 26, 17[A61K, C07D]
9850310 CD123 binding agents and uses thereofSep 03, 15Dec 26, 17[A61K, C07K]
9850318 Antibodies to quetiapine haptens and use thereofAug 20, 13Dec 26, 17[G01N, C07K]
9845319 Amide substituted thiazoles as modulators of RORytOct 30, 15Dec 19, 17[A61K, C07D]
9845326 Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitorsMar 07, 12Dec 19, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0128,451 DOSING REGIMEN ASSOCIATED WITH LONG ACTING INJECTABLE PALIPERIDONE ESTERSAbandonedAug 25, 16May 11, 17[A61K]
2016/0176,844 PROCESSES FOR THE PREPARATION OF A DIARYLTHIOHYDANTOIN COMPOUNDAbandonedDec 17, 15Jun 23, 16[C07D, B01J]
2016/0122,833 Quasispecies analysis of JC virus DNA present in urine of healthy subjectsAbandonedApr 17, 14May 05, 16[C12Q]
2016/0022,632 COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREAMENT OF HYPERURICEMIAAbandonedMar 06, 14Jan 28, 16[A61K]
2016/0022,636 PHYSIOLOGICAL LIGANDS FOR GPR139AbandonedMar 14, 14Jan 28, 16[A61K, C12Q]
2016/0015,700 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE FOR THE TREATMENT OF HODGKIN'S LYMPHOMAAbandonedMar 13, 14Jan 21, 16[A61K]
2015/0322,120 SODIUM CHANNEL SENSITIVE CONOPEPTIDES AND ANALOGS, INCLUDING COMPOSITIONS AND METHODS THEREOFAbandonedApr 17, 13Nov 12, 15[C07K]
2015/0209,339 Hetero-Substituted Acetanilide Derivatives As Analgesic AgentsAbandonedApr 03, 15Jul 30, 15[A61K]
2015/0141,652 PROCESS FOR PREPARING 2-[(2E)-2-FLUORO-2-(3-PIPERIDINYLIDENE)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONEAbandonedSep 28, 12May 21, 15[C07D]
2015/0099,730 IMIDAZOLIN-5-ONE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCERAbandonedSep 06, 13Apr 09, 15[C07D]
2015/0086,719 USE OF TRALOPYRIL AGAINST MARINE WOODBORERSAbandonedMar 06, 13Mar 26, 15[A01N, A01M, B27K]
2015/0031,784 METHOD TO PREVENT DEACTIVATION OF METAL CATALYSTS IN CATALYTIC POLYMERISATION PROCESSESAbandonedFeb 07, 13Jan 29, 15[C08F]
2014/0364,428 5-(3-AMINOPHENYL)-5-ALKYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVESAbandonedDec 04, 12Dec 11, 14[C07D]
2014/0343,048 6-DIFLUOROMETHYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVESAbandonedDec 04, 12Nov 20, 14[C07D]
2014/0336,216 PHYSIOLOGICAL LIGANDS FOR GPR139AbandonedMar 14, 14Nov 13, 14[A61K, C12Q]
2014/0274,981 PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDEAbandonedMar 14, 14Sep 18, 14[A61K]
2014/0275,276 PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDEAbandonedMar 14, 14Sep 18, 14[A61K]
2014/0275,277 PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDEAbandonedMar 14, 14Sep 18, 14[A61K]
2014/0275,576 PROCESS FOR THE PREPARATION OF (2,3-DIHYDRO-BENZO[B][1,4]DIOXIN-2-YL) METHANOL DERIVATIVESAbandonedMar 13, 14Sep 18, 14[C07D]
2014/0221,322 HETEROARYL SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASEAbandonedNov 05, 13Aug 07, 14[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.